Search filters

List of works by Felix Hilpert

A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms

scientific article published on 01 February 2019

A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.

scientific article published on June 2004

Accelerating type-specific ovarian carcinoma research: Calculator for Ovarian Subtype Prediction (COSP) is a reliable high-throughput tool for case review

scientific article published on 02 September 2013

Addition of vandetanib to pegylated liposomal doxorubicin (PLD) in patients with recurrent ovarian cancer. A randomized phase I/II study of the AGO Study Group (AGO-OVAR 2.13).

scientific article published on 5 September 2013

Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study

scientific article

An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma

scientific article published in January 2007

Anti-idiotypic antibody abagovomab in advanced ovarian cancer

scientific article published on December 2008

Aromatase inhibitors: a safety comparison

scientific article published on March 2007

Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study

scientific article published on 28 May 2020

Aurora kinase inhibitor AZD1152 has an additional effect of platinum on a sequential application at the human ovarian cancer cell line SKOV3.

scientific article published on 7 February 2013

Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial.

scientific article

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

scientific article

Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial

scientific article published on 17 March 2014

Borderline tumours of the ovary: A cohort study of the Arbeitsgmeinschaft Gynäkologische Onkologie (AGO) Study Group

scientific article published on 13 March 2013

Breakpoint characterization of the der(19)t(11;19)(q13;p13) in the ovarian cancer cell line SKOV-3.

scientific article published on 30 January 2013

Congenital retroperitoneal vascular anomalies: impact on pelvic surgery

scientific article published on 24 December 2010

Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914].

scientific article published on 25 July 2016

Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)

scientific article published on 12 April 2019

Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions

scientific article published on 05 December 2018

Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy

scientific article published on 03 July 2019

Diagnosis and management of an unilateral giant fibroadenoma of the breast in pregnancy ⬇️

scientific article published on May 25, 2011

Dilution of Molecular-Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer

scientific article published on 16 September 2019

Docetaxel-induced nail changes--a neurogenic mechanism: a case report

scientific article

Double inferior vena cava: a crucial finding complicating para-aortic lymphadenectomy ⬇️

scientific article published on September 29, 2010

Early treatment modifications improve chemotherapy adherence in ovarian cancer patients ≥70 years

scientific article published on 21 March 2019

Efficacy and safety of AEZS-108 (INN: Zoptarelin Doxorubicin Acetate) an LHRH agonist linked to doxorubicin in women with platinum refractory or resistant ovarian cancer expressing LHRH receptors: A multicenter Phase II trial of the ago-study group (

Efficacy and safety of AEZS-108 (LHRH agonist linked to doxorubicin) in women with advanced or recurrent endometrial cancer expressing LHRH receptors: a multicenter phase 2 trial (AGO-GYN5).

scientific article

Efficacy and safety of fosaprepitant for the prevention of nausea and emesis during 5 weeks of chemoradiotherapy for cervical cancer (the GAND-emesis study): a multinational, randomised, placebo-controlled, double-blind, phase 3 trial.

scientific article published on 4 March 2016

Electrofusion generates diverse DC-tumour cell hybrids for cancer immunotherapy.

scientific article

Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition

scientific article published on 7 April 2015

Evaluation of potentially predictive markers for anti-angiogenic therapy with sunitinib in recurrent ovarian cancer patients

scientific article published on June 2013

Evaluation of two different vacuum-assisted breast biopsy systems: Mammotome(R) system 11G/8G vs. ATEC(R) system 12G/9G

scientific article published on 14 January 2013

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer

scientific article

Frequent translocations of 11q13.2 and 19p13.2 in ovarian cancer

scientific article published on 24 February 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract

scientific article

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors).

scientific article

Gynecologic Cancer InterGroup (GCIG) consensus review for squamous cell carcinoma of the ovary

scientific article

Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised

article

High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells.

scientific article published on 27 December 2012

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Number 032/034-OL, April 2018) – Part 2 with Recommendations on the Therapy and Follow-up of Endometrial Cancer, Palliative C

scientific article published on 26 November 2018

Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors o

article published in 2018

LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial

scientific article published on 16 September 2020

Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study

scientific article published on 11 February 2019

MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum

scientific article published on 21 August 2020

Mammary fibroblasts regulate morphogenesis of normal and tumorigenic breast epithelial cells by mechanical and paracrine signals

scientific article published on 07 July 2012

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

scientific article published on 16 December 2017

Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib versus Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer

scientific article published on 15 August 2023

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

scientific article

Neoadjuvant Chemotherapy Cannot Be Regarded as Adequate Routine Therapy Strategy of Advanced Ovarian Cancer ⬇️

scientific article published on February 1, 2012

Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects

scientific article published on 9 May 2008

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

scientific article

Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study

scientific article published on 28 November 2016

Patient-reported outcome results from the open-label phase III AURELIA trial evaluating bevacizumab-containing therapy for platinum-resistant ovarian cancer.

scientific article published on 31 March 2014

Patient-reported outcomes and final overall survival results from the randomized phase 3 PENELOPE trial evaluating pertuzumab in low tumor human epidermal growth factor receptor 3 (HER3) mRNA-expressing platinum-resistant ovarian cancer

scientific article published on 15 August 2019

Patient-reported outcomes in ovarian cancer: are they key factors for decision making?

scientific article published on 01 October 2018

Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense?

scientific article published on 03 December 2020

Predicting the course of disease in recurrent vulvar cancer - A subset analysis of the AGO-CaRE-1 study

scientific article published on 17 July 2019

Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study

scientific article published on 18 June 2019

Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).

scientific article published on 20 October 2017

Prognostic factors for complete debulking in first- and second-line ovarian cancer.

scientific article published on December 2009

Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany

scientific article published in January 2009

Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles

scientific article

Quality of life in patients with recurrent ovarian cancer treated with niraparib versus placebo (ENGOT-OV16/NOVA): results from a double-blind, phase 3, randomised controlled trial

scientific article published on 17 July 2018

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

scientific article published on 23 October 2016

Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.

scientific article published in February 2006

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer-The GCIG Symptom Benefit Study

scientific article published on 8 June 2017

Reply to F. Tomao et al

scientific article published on 02 September 2014

Role of cytoreductive surgery in recurrent ovarian cancer.

scientific article

Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.

scientific article published on May 2011

Role of tumour-free margin distance for loco-regional control in vulvar cancer-a subset analysis of the Arbeitsgemeinschaft Gynäkologische Onkologie CaRE-1 multicenter study.

scientific article

Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial.

scientific article published on 18 November 2016

Sensitivity and specificity of loss of heterozygosity analysis for the classification of rare germline variants in <i>BRCA1/2</i>: results of the observational AGO-TR1 study (NCT02222883)

scientific article published on 03 December 2020

Simultaneous congener-specific determination of selected organochlorine compounds and nitro musks in human whole blood samples by solid-phase extraction and capillary gas chromatography with electron capture detection

scientific article published in March 2005

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

scientific article published on 09 August 2018

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

scientific article published on 18 January 2013

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article

Surgery for recurrent ovarian cancer

scientific article published on 01 September 2011

Systemic therapy in recurrent ovarian cancer: current treatment options and new drugs.

scientific article published on January 2010

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)

scientific article published on 15 August 2019

Temsirolimus in women with platinum-refractory/resistant ovarian cancer or advanced/recurrent endometrial carcinoma. A phase II study of the AGO-study group (AGO-GYN8).

scientific article published on 28 December 2015

The use of aromatase inhibitors in adjuvant therapy for early breast cancer

scientific article

Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials ⬇️

scientific article published on August 6, 2010

Treatment of Elderly Ovarian Cancer Patients in the Context of Controlled Clinical Trials: A Joint Analysis of the AGO Germany Experience ⬇️

scientific article published on February 24, 2012

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).

scientific article

What is the evidence for lymphadenectomy in presumed early ovarian cancer?

scientific article published on 01 January 2019

[Evaluating treatment from the point of view of the patient -PROs (patient-reported outcomes)]

scientific article published on 10 June 2009

[Use in special patient groups: beta-sympathomimetics in children and pregnant women]

scientific article published on 01 September 2011

Paulina is supported by:

About Paulina

Help